Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 9 » default
Psoriasis: Targets and Therapy
ISSN: 2230-326X
- View all (136)
- Volume 14, 2024 (3)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 9, 2019
Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
Ly K, Beck KM, Smith MP, Orbai AM, Liao W
Psoriasis: Targets and Therapy 2019, 9:97-107
Published Date: 28 August 2019
Psoriasis and uveitis: links and risks
Fotiadou C, Lazaridou E
Psoriasis: Targets and Therapy 2019, 9:91-96
Published Date: 28 August 2019
A narrative review of psoriasis and multiple sclerosis: links and risks
Silfvast-Kaiser AS, Homan KB, Mansouri B
Psoriasis: Targets and Therapy 2019, 9:81-90
Published Date: 22 August 2019
Psoriasis and alcohol
Svanström C, Lonne-Rahm SB, Nordlind K
Psoriasis: Targets and Therapy 2019, 9:75-79
Published Date: 21 August 2019
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Chiricozzi A, De Simone C, Fossati B, Peris K
Psoriasis: Targets and Therapy 2019, 9:73-74
Published Date: 15 August 2019
Acrodermatitis continua of Hallopeau: clinical perspectives
Smith MP, Ly K, Thibodeaux Q, Bhutani T, Liao W, Beck KM
Psoriasis: Targets and Therapy 2019, 9:65-72
Published Date: 9 August 2019
Serum TSLP is a potential biomarker of psoriasis vulgaris activity
El-Ghareeb MI, Helmy A, Al Kazzaz S, Samir H
Psoriasis: Targets and Therapy 2019, 9:59-63
Published Date: 30 July 2019
Investigation of psoriasis skin tissue by label-free multi-modal imaging: a case study on a phototherapy-treated patient
Agarwal NR, Dowlatshahi Pour M, Vandikas MS, Neittaanmäki N, Osmancevic A, Malmberg P
Psoriasis: Targets and Therapy 2019, 9:43-57
Published Date: 17 July 2019
Diagnosis and screening of patients with generalized pustular psoriasis
Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T
Psoriasis: Targets and Therapy 2019, 9:37-42
Published Date: 20 June 2019
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
Chiricozzi A, De Simone C, Fossati B, Peris K
Psoriasis: Targets and Therapy 2019, 9:29-35
Published Date: 24 May 2019
Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
Budamakuntla L, Shree-Lakshmi HV, Bansal A, Venkatarayaraju SK
Psoriasis: Targets and Therapy 2019, 9:19-27
Published Date: 3 May 2019
Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris
Strohbuecker L, Koenen H, van Rijssen E, van Cranenbroek B, Fasse E, Joosten I, Körber A, Bergmann C
Psoriasis: Targets and Therapy 2019, 9:7-17
Published Date: 12 February 2019
Type 2 diabetes and psoriasis: links and risks
Holm JG, Thomsen SF
Psoriasis: Targets and Therapy 2019, 9:1-6
Published Date: 17 January 2019